Evolution of the Clinical, Dermoscopic and Pathologic Diagnosis of Melanoma
Keywords:
melanoma, dermoscopy, dermatoscopy, pathologyAbstract
The conventional narrative states that the steadily rising incidence of melanoma among fair-skinned Caucasian populations during the last decades is caused by excessive UV-exposure. There is, however, no doubt that other factors had a significant impact on the rising incidence of melanoma. Pre-1980s the clinical diagnosis of melanoma was based on gross criteria such as ulceration or bleeding. Melanomas were often diagnosed in advanced stages when the prognosis was grim. In the mid-1980s education campaigns such as the propagation of the ABCD criteria, which addressed health care professionals and the public alike, shifted the focus towards early recognition. Dermatoscopy, which became increasingly popular in the mid-1990s, improved the accuracy for the diagnosis of melanoma in comparison to inspection with the unaided eye, especially for flat and small lesions lacking ABCD criteria. At the same time, pathologists began to lower their thresholds, particularly for the diagnosis of melanoma in situ. The melanoma epidemic that followed was mainly driven by an increase in the number of in situ or microinvasive melanomas. In a few decades, the landscape shifted from an undercalling to an overcalling of melanomas, a development that is now met with increased criticism. The gold standard of melanoma diagnosis is still conventional pathology, which is faced with low to moderate interobserver agreement. New insights in the molecular landscape of melanoma did not translate into techniques for the reliable diagnosis of gray zone lesions including small lesions. The aim of this review is to put our current view of melanoma diagnosis in historical context and to provide a narrative synthesis of its evolution. Based on this narrative I will provide suggestions on how to rebuild the trust in melanoma diagnosis accuracy and in the benefit of early recognition.
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70. DOI:10.3322/caac.21590.
Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. International journal of cancer. 1997;73. DOI:10.1002/(sici)1097-0215(19971009)73:2<198::aid-ijc6>3.0.co;2-r.
Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat. 2007;28. DOI:10.1002/humu.20481.
Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12. DOIi:10.1023/a:1008980919928.
Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller AC, Halpern AC. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. J Natl Cancer Inst. 2015;108. DOI:10.1093/jnci/djv294.
Olsen CM, Green AC, Pandeya N, Whiteman DC. Trends in Melanoma Incidence Rates in Eight Susceptible Populations through 2015. J Invest Dermatol. 2019;139. DOI:10.1016/j.jid.2018.12.006.
Welch HG, Mazer BL, Adamson AS. The Rapid Rise in Cutaneous Melanoma Diagnoses. N Engl J Med. 2021;384: 72–79. DOI: 10.1056/NEJMsb2019760.
Nufer KL, Raphael AP, Soyer HP. Dermoscopy and Overdiagnosis of Melanoma In Situ. JAMA Dermatol. 2018;154. DOI:10.1001/jamadermatol.2017.6448.
Kutzner H, Jutzi TB, Krahl D, Krieghoff-Henning EI, Heppt MV, Hekler A, et al. Overdiagnosis of melanoma - causes, consequences and solutions. J Dtsch Dermatol Ges. 2020;18. DOI:10.1111/ddg.14233.
Friedman RJ, Rigel DS. The clinical features of malignant melanoma. Dermatol Clin. 1985;3. Accessed: April 2021. https://pubmed.ncbi.nlm.nih.gov/3830490/
Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin. 2010;60. DOI:10.3322/caac.20074.
Mackie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermatol. 1991;16. DOI:10.1111/j.1365-2230.1991.tb00329.x.
Keefe M, Dick DC, Wakeel RA. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin Exp Dermatol. 1990;15. DOI:10.1111/j.1365-2230.1990.tb02064.x.
Nachbar F, Stolz W, Merkle T, Cognetta AB, Vogt T, Landthaler M, et al. The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol. 1994;30: 551–559. DOI: 10.1016/S0190-9622(94)70061-3.
Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol. 1998;134: 1563–1570. DOI: 10.1001/archderm.134.12.1563.
Ackerman AB. No one should die of malignant melanoma. J Am Acad Dermatol. 1985;12: 115–116. DOI: 10.1016/S0190-9622(85)80242-5.
Koga H, Saida T. Revised 3-step dermoscopic algorithm for the management of acral melanocytic lesions. Arch Dermatol. 2011;147: 741–743. DOI: 10.1001/archdermatol.2011.136.
Benati E, Ribero S, Longo C, Piana S, Puig S, Carrera C, et al. Clinical and dermoscopic clues to differentiate pigmented nail bands: an International Dermoscopy Society study. J Eur Acad Dermatol Venereol. 2017;31. DOI:10.1111/jdv.13991.
Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292. DOI:10.1001/jama.292.22.2771.
Merten JW, Hamadi HY, King JL. Cancer Risk Perceptions Among People Who Check Their Skin for Skin Cancer: Results from the 2017 U.S. Health Information National Trends Survey (HINTS). J Cancer Educ. 2020 [cited 25 Apr 2021]. DOI:10.1007/s13187-020-01880-5.
Paul E, Henkelmann A, Bödeker RH. [Growth dynamics and histogenesis of malignant melanomas based on anamnestic data]. Z Hautkr. 1988;63. Accessed: April 2021. https://pubmed.ncbi.nlm.nih.gov/3407262/
Slue WE. Total body photography for melanoma surveillance. N Y State J Med. 1992;92. Accessed: April 2021. https://pubmed.ncbi.nlm.nih.gov/1488206/
Halpern AC. Total body skin imaging as an aid to melanoma detection. Semin Cutan Med Surg. 2003;22. DOI:10.1053/sder.2003.50000.
Feit NE, Dusza SW, Marghoob AA. Melanomas detected with the aid of total cutaneous photography. Br J Dermatol. 2004;150.DOI:10.1111/j.0007-0963.2004.05892.x.
Deinlein T, Michor C, Hofmann-Wellenhof R, Schmid-Zalaudek K, Fink-Puches R. The importance of total-body photography and sequential digital dermatoscopy for monitoring patients at increased melanoma risk. J Dtsch Dermatol Ges. 2020;18. DOI:10.1111/ddg.14158.
Ji-Xu A, Dinnes J, Matin RN. Total body photography for the diagnosis of cutaneous melanoma in adults: a systematic review and meta-analysis. Br J Dermatol. 2020. DOI:10.1111/bjd.19759.
Kittler H. Total body photography for secondary prevention of melanoma. Br J Dermatol. 2021. DOI:10.1111/bjd.20058.
Grob JJ, Bonerandi JJ. The “ugly duckling” sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Archives of dermatology. 1998. pp. 103–104. DOI: 10.1001/archderm.134.1.103-a.
Argenziano G, Catricalà C, Ardigo M, Buccini P, De Simone P, Eibenschutz L, et al. Dermoscopy of patients with multiple nevi: Improved management recommendations using a comparative diagnostic approach. Arch Dermatol. 2011;147: 46–49. DOI: 10.1001/archdermatol.2010.389.
Soenksen LR, Kassis T, Conover ST, Marti-Fuster B, Birkenfeld JS, Tucker-Schwartz J, et al. Using deep learning for dermatologist-level detection of suspicious pigmented skin lesions from wide-field images. Sci Transl Med. 2021;13. DOI:10.1126/scitranslmed.abb3652.
Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol. 1987;17: 571–583. DOI: 10.1016/S0190-9622(87)70239-4.
Menzies SW. An Atlas of Surface Microscopy of Pigmented Skin Lesions: Dermoscopy. McGraw Hill Professional; 2003.
Henning JS, Dusza SW, Wang SQ, Marghoob AA, Rabinovitz HS, Polsky D, et al. The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy. J Am Acad Dermatol. 2007;56: 45–52. DOI: 10.1016/j.jaad.2006.09.003.
Rosendahl C, Tschandl P, Cameron A, Kittler H. Diagnostic accuracy of dermatoscopy for melanocytic and nonmelanocytic pigmented lesions. J Am Acad Dermatol. 2011;64: 1068–1073. DOI: 10.1016/j.jaad.2010.03.039.
Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;3: 159–165. DOI: 10.1016/S1470-2045(02)00679-4.
Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol. 2001;137. DOI:10.1001/archderm.137.10.1343.
Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol. 2008;159. DOI:10.1111/j.1365-2133.2008.08713.x.
Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003;48: 679–693. DOI: d10.1067/mjd.2003.281.
Han B, Hur K, Ohn J, Lim SS, Mun JH. Acral lentiginous melanoma in situ: dermoscopic features and management strategy. Sci Rep. 2020;10. DOI:10.1038/s41598-020-77425-z.
Lallas A, Kyrgidis A, Koga H, Moscarella E, Tschandl P, Apalla Z, et al. The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol. 2015;173. DOI:10.1111/bjd.14045.
Saida T, Koga H, Uhara H. Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol. 2011;38. DOI:10.1111/j.1346-8138.2010.01174.x.
Schiffner R, Schiffner-Rohe J, Vogt T, Landthaler M, Wlotzke U, Cognetta AB, et al. Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol. 2000;42. DOI:10.1016/s0190-9622(00)90005-7.
Lallas A, Lallas K, Tschandl P, Kittler H, Apalla Z, Longo C, et al. The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis. J Am Acad Dermatol. 2021;84. DOI:10.1016/j.jaad.2020.06.085.
Tschandl P, Rosendahl C, Kittler H. Dermatoscopy of flat pigmented facial lesions. J Eur Acad Dermatol Venereol. 2015;29. DOI:10.1111/jdv.12483.
Menzies SW, Kreusch J, Byth K, Pizzichetta MA, Marghoob A, Braun R, et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol. 2008;144. DOI:10.1001/archderm.144.9.1120.
Pizzichetta MA, Talamini R, Stanganelli I, Puddu P, Bono R, Argenziano G, et al. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol. 2004;150. DOI:10.1111/j.1365-2133.2004.05928.x.
Menzies SW, Moloney FJ, Byth K, Avramidis M, Argenziano G, Zalaudek I, et al. Dermoscopic evaluation of nodular melanoma. JAMA Dermatol. 2013;149. DOI:10.1001/jamadermatol.2013.2466.
Pizzichetta MA, Kittler H, Stanganelli I, Bono R, Cavicchini S, De Giorgi V, et al. Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis. Br J Dermatol. 2015;173. DOI:10.1111/bjd.13861.
Blum A, Simionescu O, Argenziano G, Braun R, Cabo H, Eichhorn A, et al. Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction: results of a multicenter study by the International Dermoscopy Society (IDS). Arch Dermatol. 2011;147. DOI:10.1001/archdermatol.2011.155.
Braun RP, Baran R, Le Gal FA, Dalle S, Ronger S, Pandolfi R, et al. Diagnosis and management of nail pigmentations. J Am Acad Dermatol. 2007;56. DOI:10.1016/j.jaad.2006.12.021.
Thomas L, Dalle S. Dermoscopy provides useful information for the management of melanonychia striata. Dermatol Ther. 2007;20. DOI:10.1111/j.1529-8019.2007.00106.x.
Ronger S, Touzet S, Ligeron C, Balme B, Viallard AM, Barrut D, et al. Dermoscopic examination of nail pigmentation. Arch Dermatol. 2002;138. DOI:10.1001/archderm.138.10.1327.
Starace M, Alessandrini A, Brandi N, Piraccini BM. Use of Nail Dermoscopy in the Management of Melanonychia: Review. Dermatology practical & conceptual. 2019;9. DOI:10.5826/dpc.0901a10.
Jaimes N, Marghoob AA, Rabinovitz H, Braun RP, Cameron A, Rosendahl C, et al. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin. J Am Acad Dermatol. 2015;72. DOI:10.1016/j.jaad.2015.02.1117.
Bono A, Bartoli C, Baldi M, Moglia D, Tomatis S, Tragni G, et al. Micro-melanoma detection. A clinical study on 22 cases of melanoma with a diameter equal to or less than 3 mm. Tumori. 2004;90. Accessed: April 2021. https://pubmed.ncbi.nlm.nih.gov/15143985/
Bono A, Tolomio E, Trincone S, Bartoli C, Tomatis S, Carbone A, et al. Micro-melanoma detection: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter. Br J Dermatol. 2006;155. DOI:10.1111/j.1365-2133.2006.07396.x.
Rosendahl C, Cameron A, Bulinska A, Harding-Smith D, Weedon D. Embryology of a melanoma? A case report with speculation based on dermatoscopic and histologic evidence. Dermatology practical & conceptual. 2012;2. DOI:10.5826/dpc.0204a08.
Inskip M, Magee J, Weedon D, Rosendahl C. When algorithms falter: a case report of a very small melanoma excised due to the dermatoscopic “ugly duckling” sign. Dermatology practical & conceptual. 2013;3. DOI:10.5826/dpc.0302a09.
Argenziano G, Cerroni L, Zalaudek I, Staibano S, Hofmann-Wellenhof R, Arpaia N, et al. Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol. 2012;67. DOI:10.1016/j.jaad.2011.07.019.
Babino G, Lallas A, Agozzino M, Alfano R, Apalla Z, Brancaccio G, et al. Melanoma diagnosed on digital dermoscopy monitoring: A side-by-side image comparison is needed to improve early detection. J Am Acad Dermatol. 2020. DOI:10.1016/j.jaad.2020.07.013.
Tschandl P, Hofmann L, Fink C, Kittler H, Haenssle HA. Melanomas vs. nevi in high-risk patients under long-term monitoring with digital dermatoscopy: do melanomas and nevi already differ at baseline? J Eur Acad Dermatol Venereol. 2017;31: 972–977. DOI. 10.1111/jdv.14065.
Jaimes N, Dusza SW, Quigley EA, Braun RP, Puig S, Malvehy J, et al. Influence of time on dermoscopic diagnosis and management. Australas J Dermatol. 2013;54: 96–104. DOI: 10.1111/ajd.12001.
Skvara H, Teban L, Fiebiger M, Binder M, Kittler H. Limitations of dermoscopy in the recognition of melanoma. Arch Dermatol. 2005;141: 155–160. DOI: 10.1001/archderm.141.2.155.
Kittler H, Pehamberger H, Wolff K, Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: Patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol. 2000;43: 467–476. DOI: 10.1067/mjd.2000.107504.
Kittler H, Binder M. Follow-up of melanocytic skin lesions with digital dermoscopy: risks and benefits. Archives of dermatology. 2002. p. 1379. DOI: 10.1001/archderm.138.10.1379.
Salerni G, Terán T, Puig S, Malvehy J, Zalaudek I, Argenziano G, et al. Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society. J Eur Acad Dermatol Venereol. 2013;27: 805–814. DOI: 10.1111/jdv.12032.
Menzies SW, Emery J, Staples M, Davies S, McAvoy B, Fletcher J, et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol. 2009;161: 1270–1277. DOI: 10.1111/j.1365-2133.2009.09374.x.
Haenssle HA, Krueger U, Vente C, Thoms K-M, Bertsch HP, Zutt M, et al. Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. J Invest Dermatol. 2006;126: 980–985. DOI. 10.1038/sj.jid.5700119.
Carli P. Identification of Incipient Tumors by Means of Sequential Dermoscopy Imaging: A New Way to Inflate the “Epidemic” of Melanoma? Archives of Dermatology. 2007. p. 799. DOI:10.1001/archderm.143.6.805-a.
Haenssle HA, Winkler JK, Fink C, Toberer F, Enk A, Stolz W, et al. Skin lesions of face and scalp - Classification by a market-approved convolutional neural network in comparison with 64 dermatologists. Eur J Cancer. 2021;144: 192–199. DOI: 10.1016/j.ejca.2020.11.034.
Tschandl P, Codella N, Akay BN, Argenziano G, Braun RP, Cabo H, et al. Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study. Lancet Oncol. 2019;20: 938–947. DOI. 10.1016/S1470-2045(19)30333-X.
Tschandl P, Rinner C, Apalla Z, Argenziano G, Codella N, Halpern A, et al. Human-computer collaboration for skin cancer recognition. Nat Med. 2020. DOI:10.1038/s41591-020-0942-0.
Winkler JK, Sies K, Fink C, Toberer F, Enk A, Deinlein T, et al. Melanoma recognition by a deep learning convolutional neural network-Performance in different melanoma subtypes and localisations. Eur J Cancer. 2020;127: 21–29. DOI: 10.1016/j.ejca.2019.11.020.
Haenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A, et al. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann Oncol. 2018;29: 1836–1842. DOI: 10.1093/annonc/mdy166.
Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, et al. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task. Eur J Cancer. 2019;113: 47–54. DOI: 10.1016/j.ejca.2019.04.001.
Ackerman LV. Malignant melanoma of the skin; clinical and pathologic analysis of 75 cases. Am J Clin Pathol. 1948;18: 602–624. DOI. 10.1093/ajcp/18.8.602.
Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6: 1–45.DOI: 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C.
Mihm MC, Clark WH, From L. The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med. 1971;284. DOI: 10.1056/NEJM197105132841907.
Clark WH, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29. Accessed: April 2021. https://pubmed.ncbi.nlm.nih.gov/5773814/
Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172. DOI:10.1097/00000658-197011000-00017.
Breslow A. Tumor thickness in evaluating prognosis of cutaneous melanoma. Ann Surg. 1978;187. DOI:10.1097/00000658-197804000-00020.
Price NM, Rywlin AM, Ackerman AB. Histologic criteria for the diagnosis of superficial spreading malignant melanoma: formulated on the basis of proven metastatic lesions. Cancer. 1976;38. DOI:10.1002/1097-0142(197612)38:6<2434::aid-cncr2820380631>3.0.co;2-n.
NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA. 1992;268. DOI:10.1001/jama.1992.03490100112037.
Ferrara G, Argenziano G, Soyer HP, D’Argenio P, Carli P, Cerroni L, et al. Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot study. Tumori. 2000;86. Accessed: April 2021. https://pubmed.ncbi.nlm.nih.gov/11218183/ DOI: 10.1177/030089160008600602.
Lodha S, Saggar S, Celebi JT, Silvers DN. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol. 2008;35.DOI:10.1111/j.1600-0560.2007.00970.x.
Shoo BA, Sagebiel RW, Kashani-Sabet M. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol. 2010;62. DOI:10.1016/j.jaad.2009.09.043.
Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, et al. Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ. 2017;357. DOI:10.1136/bmj.j2813.
Gerami P, Busam K, Cochran A, Cook MG, Duncan LM, Elder DE, et al. Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol. 2014;38. DOI:10.1097/PAS.0000000000000198.
Pusiol T, Morichetti D, Piscioli F, Zorzi MG. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation. Pathologica. 2012;104. Accessed: April 2021. https://pubmed.ncbi.nlm.nih.gov/22953503/
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417. DOI:10.1038/nature00766.
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353. DOI:10.1056/NEJMoa050092.
Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545. DOI:10.1038/nature22071.
Karasarides M, Chiloeches A, Hayward R, Niculescu-Duvaz D, Scanlon I, Friedlos F, et al. B-RAF is a therapeutic target in melanoma. Oncogene. 2004;23. DOI:10.1038/sj.onc.1207785.
Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013;37. DOI:10.1097/PAS.0b013e3182753de6.
Miedema J, Andea AA. Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis. Mod Pathol. 2020;33. DOI:10.1038/s41379-020-0490-7.
Ferrara G, Argenyi Z, Argenziano G, Cerio R, Cerroni L, Di Blasi A, et al. The influence of clinical information in the histopathologic diagnosis of melanocytic skin neoplasms. PLoS One. 2009;4. DOI:10.1371/journal.pone.0005375.
Brinker TJ, Schmitt M, Krieghoff-Henning EI, Barnhill R, Beltraminelli H, Braun SA, et al. Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists. J Am Acad Dermatol. 2021. DOI:10.1016/j.jaad.2021.02.009.
Hekler A, Utikal JS, Enk AH, Solass W, Schmitt M, Klode J, et al. Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images. Eur J Cancer. 2019;118: 91–96. DOI: 10.1016/j.ejca.2019.06.012.
Published
Issue
Section
License
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
